TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 39.43 USD -1.03% Market Closed
Market Cap: 6.3B USD

Wall Street
Price Targets

TGTX Price Targets Summary
TG Therapeutics Inc

Wall Street analysts forecast TGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TGTX is 43.35 USD with a low forecast of 11.11 USD and a high forecast of 57.75 USD.

Lowest
Price Target
11.11 USD
72% Downside
Average
Price Target
43.35 USD
10% Upside
Highest
Price Target
57.75 USD
46% Upside
TG Therapeutics Inc Competitors:
Price Targets
PBYI
Puma Biotechnology Inc
23% Upside
MRUS
Merus NV
62% Upside
CYTK
Cytokinetics Inc
119% Upside
4974
Takara Bio Inc
60% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
0% Downside
MIRM
Mirum Pharmaceuticals Inc
46% Upside
1952
Everest Medicines Ltd
1% Downside
SLNO
Soleno Therapeutics Inc
38% Upside

Revenue
Forecast

Revenue Estimate
TG Therapeutics Inc

For the last 8 years the compound annual growth rate for TG Therapeutics Inc's revenue is 161%. The projected CAGR for the next 3 years is 48%.

161%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 128%.

N/A
Past Growth
128%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 157%.

N/A
Past Growth
157%
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TGTX's stock price target?
Price Target
43.35 USD

According to Wall Street analysts, the average 1-year price target for TGTX is 43.35 USD with a low forecast of 11.11 USD and a high forecast of 57.75 USD.

What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
48%

For the last 8 years the compound annual growth rate for TG Therapeutics Inc's revenue is 161%. The projected CAGR for the next 3 years is 48%.

What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
128%

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 128%.

What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
157%

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 157%.

Back to Top